150 related articles for article (PubMed ID: 17110431)
1. Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54.
Yang Z; Chang YJ; Miyamoto H; Yeh S; Yao JL; di Sant'Agnese PA; Tsai MY; Chang C
Endocrinology; 2007 Mar; 148(3):1340-9. PubMed ID: 17110431
[TBL] [Abstract][Full Text] [Related]
2. Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth.
Yang Z; Chang YJ; Miyamoto H; Ni J; Niu Y; Chen Z; Chen YL; Yao JL; di Sant'Agnese PA; Chang C
Mol Endocrinol; 2007 Feb; 21(2):343-58. PubMed ID: 17082327
[TBL] [Abstract][Full Text] [Related]
3. A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.
Miyamoto H; Rahman M; Takatera H; Kang HY; Yeh S; Chang HC; Nishimura K; Fujimoto N; Chang C
J Biol Chem; 2002 Feb; 277(7):4609-17. PubMed ID: 11673464
[TBL] [Abstract][Full Text] [Related]
4. Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity.
Ting HJ; Bao BY; Hsu CL; Lee YF
Endocrine; 2005 Feb; 26(1):1-9. PubMed ID: 15805579
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth.
Hsu CL; Chen YL; Ting HJ; Lin WJ; Yang Z; Zhang Y; Wang L; Wu CT; Chang HC; Yeh S; Pimplikar SW; Chang C
Mol Endocrinol; 2005 Feb; 19(2):350-61. PubMed ID: 15514032
[TBL] [Abstract][Full Text] [Related]
6. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor.
Kang HY; Yeh S; Fujimoto N; Chang C
J Biol Chem; 1999 Mar; 274(13):8570-6. PubMed ID: 10085091
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer.
Yeh S; Sampson ER; Lee DK; Kim E; Hsu CL; Chen YL; Chang HC; Altuwaijri S; Huang KE; Chang C
J Formos Med Assoc; 2000 Dec; 99(12):885-94. PubMed ID: 11155740
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C
J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969
[TBL] [Abstract][Full Text] [Related]
9. Negative modulation of androgen receptor transcriptional activity by Daxx.
Lin DY; Fang HI; Ma AH; Huang YS; Pu YS; Jenster G; Kung HJ; Shih HM
Mol Cell Biol; 2004 Dec; 24(24):10529-41. PubMed ID: 15572661
[TBL] [Abstract][Full Text] [Related]
10. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells.
Lin HK; Altuwaijri S; Lin WJ; Kan PY; Collins LL; Chang C
J Biol Chem; 2002 Sep; 277(39):36570-6. PubMed ID: 12119296
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer: prognostic significance of the association of heterogeneous nuclear ribonucleoprotein K and androgen receptor expression.
Barboro P; Salvi S; Rubagotti A; Boccardo S; Spina B; Truini M; Carmignani G; Introini C; Ferrari N; Boccardo F; Balbi C
Int J Oncol; 2014 May; 44(5):1589-98. PubMed ID: 24626777
[TBL] [Abstract][Full Text] [Related]
13. TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3.
Mu X; Chang C
Prostate; 2003 Oct; 57(2):129-33. PubMed ID: 12949936
[TBL] [Abstract][Full Text] [Related]
14. In vitro gene expression changes of androgen receptor coactivators after hormone deprivation in an androgen-dependent prostate cancer cell line.
Chang HC; Chen SC; Chen J; Hsieh JT
J Formos Med Assoc; 2005 Sep; 104(9):652-8. PubMed ID: 16276440
[TBL] [Abstract][Full Text] [Related]
15. CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction.
Suh JH; Shong M; Choi HS; Lee K
Mol Endocrinol; 2008 Jan; 22(1):33-46. PubMed ID: 17885209
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor activity is affected by both nuclear matrix localization and the phosphorylation status of the heterogeneous nuclear ribonucleoprotein K in anti-androgen-treated LNCaP cells.
Barboro P; Borzì L; Repaci E; Ferrari N; Balbi C
PLoS One; 2013; 8(11):e79212. PubMed ID: 24236111
[TBL] [Abstract][Full Text] [Related]
17. Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer.
Hu YC; Yeh S; Yeh SD; Sampson ER; Huang J; Li P; Hsu CL; Ting HJ; Lin HK; Wang L; Kim E; Ni J; Chang C
J Biol Chem; 2004 Aug; 279(32):33438-46. PubMed ID: 15166229
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation.
Mukhopadhyay NK; Kim J; Cinar B; Ramachandran A; Hager MH; Di Vizio D; Adam RM; Rubin MA; Raychaudhuri P; De Benedetti A; Freeman MR
Cancer Res; 2009 Mar; 69(6):2210-8. PubMed ID: 19258514
[TBL] [Abstract][Full Text] [Related]
19. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
[TBL] [Abstract][Full Text] [Related]
20. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
